The implications of sortilin/vps10p domain receptors in neurological and human diseases

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 8, 2014, Pages 1354-1365

  Wilson, Cornelia M ^a   Naves, Thomas ^a   Saada, Sofiane ^a   Pinet, Sandra ^a   Vincent, François ^a,b   Lalloué, Fabrice ^a   Jauberteau, Marie Odile ^a  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Alzheimer s disease; Cancer; Parkinson disease; Sortilin; Type 2 diabetes mellitus; Vacuolar protein sorting 10 protein

Indexed keywords

ADAPTOR PROTEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; CATHEPSIN; GLUCOSE TRANSPORTER 4; HUNTINGTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUROTENSIN; NEUROTENSIN RECEPTOR; PROGRANULIN; PROTEIN P75; RECEPTOR; SORTILIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; VACUOLAR PROTEIN SORTING 10 PROTEIN DOMAIN RECEPTOR; CELL SURFACE RECEPTOR; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CARDIOVASCULAR DISEASE; FRONTOTEMPORAL DEMENTIA; GENE; HUMAN; LYSOSOME STORAGE DISEASE; NEOPLASM; NERVE DEGENERATION; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; SORCS1 GENE; TRANS GOLGI NETWORK; VPS26A GENE; ANIMAL; METABOLIC DISORDER; METABOLISM;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC DISEASES; NERVOUS SYSTEM DISEASES; RECEPTORS, CELL SURFACE;

EID: 84907058201     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527313666141023151642     Document Type: Article

References (153)

1. Marcusson EG, Horazdovsky BF, Cereghino JL, Gharakhanian E, Emr SD. The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene. Cell 1994; 77(4): 579-86.
2. Mazella J, Zsurger N, Navarro V, et al. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem 1998; 273(41): 26273-6.
3. Hermey G, Keat SJ, Madsen P, et al. Characterization of sorCS1, an alternatively spliced receptor with completely different cytoplasmic domains that mediate different trafficking in cells. J Biol Chem 2003; 278(9): 7390-6.
4. Jacobsen L, Madsen P, Jacobsen C, et al. Activation and functional characterization of the mosaic receptor SorLA/LR11. J Biol Chem 2001; 276(25): 22788-96.
5. Munck Petersen C, Nielsen MS, Jacobsen C, et al. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding. EMBO J 1999; 18(3): 595-604.
6. Westergaard UB, Kirkegaard K, Sorensen ES, et al. SorCS3 does not require propeptide cleavage to bind nerve growth factor. FEBS Lett 2005; 579(5): 1172-6.
7. Westergaard UB, Sorensen ES, Hermey G, et al. Functional organization of the sortilin Vps10p domain. J Biol Chem 2004; 279(48): 50221-9.
8. Quistgaard EM, Madsen P, Groftehauge MK, et al. Ligands bind to Sortilin in the tunnel of a ten-bladed beta-propeller domain. Nat Struct Mol Biol 2009; 16(1): 96-8.
9. Nykjaer A, Lee R, Teng KK, et al. Sortilin is essential for proNGFinduced neuronal cell death. Nature 2004; 427(6977): 843-8.
10. Serup Andersen O, Boisguerin P, Glerup S, et al. Identification of a linear epitope in sortilin that partakes in pro-neurotrophin binding. J Biol Chem 2010; 285(16): 12210-22.
11. Nielsen MS, Madsen P, Christensen EI, et al. The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J 2001; 20(9): 2180-90.
12. Nielsen MS, Gustafsen C, Madsen P, et al. Sorting by the cytoplasmic domain of the amyloid precursor protein binding receptor SorLA. Mol Cell Biol 2007; 27(19): 6842-51.
13. Seaman MN. Identification of a novel conserved sorting motif required for retromer-mediated endosome-to-TGN retrieval. J Cell Sci 2007; 120(Pt 14): 2378-89.
14. Canuel M, Lefrancois S, Zeng J, Morales CR. AP-1 and retromer play opposite roles in the trafficking of sortilin between the Golgi apparatus and the lysosomes. Biochem Biophys Res Commun 2008; 366(3): 724-30.
15. Mari M, Bujny MV, Zeuschner D, et al. SNX1 defines an early endosomal recycling exit for sortilin and mannose 6-phosphate receptors. Traffic 2008; 9(3): 380-93.
16. McCormick PJ, Dumaresq-Doiron K, Pluviose AS, et al. Palmitoylation controls recycling in lysosomal sorting and trafficking. Traffic 2008; 9(11): 1984-97.
17. Lefrancois S, Zeng J, Hassan AJ, Canuel M, Morales CR. The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin. EMBO J 2003; 22(24): 6430-7.
18. Ni X, Morales CR. The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6-phosphate receptor. Traffic 2006; 7(7): 889-902.
19. Navarro V, Martin S, Sarret P, et al. Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin. FEBS Lett 2001; 495(1-2): 100-5.
20. Teng HK, Teng KK, Lee R, et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 2005; 25(22): 5455-63.
21. Nilsson SK, Christensen S, Raarup MK, et al. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem 2008; 283(38): 25920-7.
22. Mazella J, Vincent JP. Functional roles of the NTS2 and NTS3 receptors. Peptides 2006; 27(10): 2469-75.
23. Botta R, Lisi S, Pinchera A, et al. Sortilin is a putative postendocytic receptor of thyroglobulin. Endocrinology 2009; 150(1): 509-18.
24. Marino M, McCluskey RT. Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am J Physiol Cell Physiol 2000; 279(5): C1295-306.
25. Nykjaer A, Willnow TE. Sortilin: A receptor to regulate neuronal viability and function. Trends Neurosci 2012; 35(4): 261-70.
26. Dal Farra C, Sarret P, Navarro V, et al. Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines. Int J Cancer 2001; 92(4): 503-9.
27. Giorgi RR, Chile T, Bello AR, et al. Expression of neurotensin and its receptors in pituitary adenomas. J Neuroendocrinol 2008; 20(9): 1052-7.
28. Truzzi F, Marconi A, Lotti R, et al. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Investig Dermatol 2008; 128(8): 2031-40.
29. Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286(5440): 735-41.
30. Sinha S, Anderson JP, Barbour R, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 1999; 402(6761): 537-40.
31. Walter J, Kaether C, Steiner H, Haass C. The cell biology of Alzheimer's disease: Uncovering the secrets of secretases. Curr Opin Neurobiol 2001; 11(5): 585-90.
32. Al-Shawi R, Hafner A, Olsen J, et al. Neurotoxic and neurotrophic roles of proNGF and the receptor sortilin in the adult and ageing nervous system. Eur J Neurosci 2008; 27(8): 2103-14.
33. Saadipour K, Yang M, Lim Y, et al. Amyloid beta (Abeta) upregulates the expression of sortilin via the p75 /RhoA signaling pathway. J Neurochem 2013; 127(2): 152-62.
34. Finan GM, Okada H, Kim TW. BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin. J Biol Chem 2011; 286(14): 12602-16.
35. Gustafsen C, Glerup S, Pallesen LT, et al. Sortilin and SorLA display distinct roles in processing and trafficking of amyloid precursor protein. J Neurosci 2013; 33(1): 64-71.
36. Mufson EJ, Wuu J, Counts SE, Nykjaer A. Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease. Neurosci Lett 2010; 471(3): 129-33.
37. Terry AV, Jr, Kutiyanawalla A, Pillai A. Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats. Physiol Behav 2011; 102(2): 149-57.
38. Xia Y, Chen BY, Sun XL, et al. Presence of proNGF-Sortilin Signaling Complex in Nigral Dopamine Neurons and Its Variation in Relation to Aging, Lactacystin and 6-OHDA Insults. Int J Mol Sci 2013; 14(7): 14085-104.
39. Nyborg AC, Ladd TB, Zwizinski CW, Lah JJ, Golde TE. Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gammasecretase substrates. Mol Neurodegener 2006; 1: 3.
40. Hermey G, Sjogaard SS, Petersen CM, Nykjaer A, Gliemann J. Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members. Biochem J 2006; 395(2): 285-93.
41. Evans SF, Irmady K, Ostrow K, et al. Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation. J Biol Chem 2011; 286(34): 29556-67.
42. Woo NH, Teng HK, Siao CJ, et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 2005; 8(8): 1069-77.
43. Longo FM, Massa SM. Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat Rev Drug Discov 2013; 12(7): 507-25.
44. Bulbarelli A, Lonati E, Cazzaniga E, et al. TrkA pathway activation induced by amyloid-beta (Abeta). Mol Cell Neurosci 2009; 40(3): 365-73.
45. Verdier Y, Zarandi M, Penke B. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J Peptide Sci 2004; 10(5): 229-48.
46. Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39(2): 168-77.
47. Diarra A, Geetha T, Potter P, Babu JR. Signaling of the neurotrophin receptor p75 in relation to Alzheimer's disease. Biochem Biophys Res Commun 2009; 390(3): 352-6.
48. Fahnestock M, Michalski B, Xu B, Coughlin MD. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 2001; 18(2): 210-20.
49. Harrington AW, Leiner B, Blechschmitt C, et al. Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc Natl Acad Sci USA 2004; 101(16): 6226-30.
50. Jansen P, Giehl K, Nyengaard JR, et al. Roles for the proneurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat Neurosci 2007; 10(11): 1449-57.
51. Kumar A, Sinha RA, Tiwari M, et al. Increased pro-nerve growth factor and p75 neurotrophin receptor levels in developing hypothyroid rat cerebral cortex are associated with enhanced apoptosis. Endocrinology 2006; 147(10): 4893-903.
52. Peng S, Wuu J, Mufson EJ, Fahnestock M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 2004; 63(6): 641-9.
53. Volosin M, Song W, Almeida RD, et al. Interaction of survival and death signaling in basal forebrain neurons: Roles of neurotrophins and proneurotrophins. J Neurosci 2006; 26(29): 7756-66.
54. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261(5123): 921-3.
55. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoformspecific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90(17): 8098-102.
56. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein Econtaining lipoproteins. Biochim Biophys Acta 1987; 917(1): 148-61.
57. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 2006; 103(15): 5644-51.
58. Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2(3): a006312.
59. Carlo AS. Sortilin, a novel APOE receptor implicated in Alzheimer disease. Prion 2013; 7(5): 378-82.
60. Carlo AS. The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-[beta] peptide in the brain. J Neurosci 2013; 33: 358-70.
61. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP- 43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314(5796): 130-3.
62. Deng HX, Zhai H, Bigio EH, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 2010; 67(6): 739-48.
63. King A, Maekawa S, Bodi I, Troakes C, Al-Sarraj S. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43. Neuropathology 2011; 31(3): 239-49.
64. Dickson DW. TDP-43 immunoreactivity in neurodegenerative disorders: Disease versus mechanism specificity. Acta Neuropathol 2008; 115(1): 147-9.
65. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393(6686): 702-5.
66. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442(7105): 916-9.
67. Hu F, Padukkavidana T, Vaegter CB, et al. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 2010; 68(4): 654-67.
68. Wu J, Yu W, Chen Y, et al. Intrastriatal transplantation of GDNFengineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model. Neurochem Res 2010; 35(3): 495-502.
69. Chen LW, Zhang JP, Kwok-Yan Shum D, Chan YS. Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated C57/Bl mice. J Comp Neurol 2006; 497(6): 898-909.
70. Chung EK, Chen LW, Chan YS, Yung KK. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. J Compar Neurol 2008; 511(4): 421-37.
71. Pedraza CE, Podlesniy P, Vidal N, et al. Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Am J Pathol 2005; 166(2): 533-43.
72. Stoica G, Lungu G, Kim HT, Wong PK. Up-regulation of pronerve growth factor, neurotrophin receptor p75, and sortilin is associated with retrovirus-induced spongiform encephalomyelopathy. Brain Res 2008; 1208: 204-16.
73. Chen LW, Yung KK, Chan YS, Shum DK, Bolam JP. The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson's disease. CNS Neurol Disord Drug Targets 2008; 7(6): 512-23.
74. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2001; 2(7): 492-501.
75. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci USA 1998; 95(11): 6469-73.
76. Uversky VN, Eliezer D. Biophysics of Parkinson's disease: Structure and aggregation of alpha-synuclein. Curr Prot Peptide Sci 2009; 10(5): 483-99.
77. Szego EM, Outeiro TF, Kermer P, Schulz JB. Impairment of the septal cholinergic neurons in MPTP-treated A30P alpha-synuclein mice. Neurobiol Aging 2013; 34(2): 589-601.
78. Wilson CM, Magnaudeix A, Yardin C, Terro F. Autophagy Dysfunction and its Link to Alzheimer's Disease and Type II Diabetes Mellitus. CNS Neurol Disord Drug Targets 2014; 13(2): 226-46.
79. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998; 15(7): 539-53.
80. Atkinson MA, Maclaren NK. The pathogenesis of insulindependent diabetes mellitus. N Engl J Med 1994; 331(21): 1428-36.
81. Clee SM, Yandell BS, Schueler KM, et al. Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet 2006; 38(6): 688-93.
82. Granhall C, Park HB, Fakhrai-Rad H, Luthman H. High-resolution quantitative trait locus analysis reveals multiple diabetes susceptibility loci mapped to intervals<800 kb in the speciesconserved Niddm1i of the GK rat. Genetics 2006; 174(3): 1565-72.
83. Goodarzi MO, Lehman DM, Taylor KD, et al. SORCS1: A novel human type 2 diabetes susceptibility gene suggested by the mouse. Diabetes 2007; 56(7): 1922-9.
84. Kooner JS, Saleheen D, Sim X, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 2011; 43(10): 984-9.
85. Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia: the rotterdam study. Neurology 1999; 53(9): 1937-42.
86. Han W, Li C. Linking type 2 diabetes and Alzheimer's disease. Proc Natl Acad Sci USA 2010; 107(15): 6557-8.
87. Paterson AD, Waggott D, Boright AP, et al. A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose. Diabetes 2010; 59(2): 539-49.
88. Liang X, Slifer M, Martin ER, et al. Genomic convergence to identify candidate genes for Alzheimer disease on chromosome 10. Hum Mutat 2009; 30(3): 463-71.
89. Lane RF, Raines SM, Steele JW, et al. Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex. J Neurosci 2010; 30(39): 13110-5.
90. Reitz C, Tokuhiro S, Clark LN, et al. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol 2011; 69(1): 47-64.
91. Lane RF, Steele JW, Cai D, et al. Protein sorting motifs in the cytoplasmic tail of SorCS1 control generation of Alzheimer's amyloid-beta peptide. J Neurosci 2013; 33(16): 7099-107.
92. Shi J, Kandror KV. Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes. Develop Cell 2005; 9(1): 99-108.
93. Shi J, Kandror KV. The luminal Vps10p domain of sortilin plays the predominant role in targeting to insulin-responsive Glut4- containing vesicles. J Biol Chem 2007; 282(12): 9008-16.
94. Lin BZ, Pilch PF, Kandror KV. Sortilin is a major protein component of Glut4-containing vesicles. J Biol Chem 1997; 272(39): 24145-7.
95. Morris NJ, Ross SA, Lane WS, et al. Sortilin is the major 110-kDa protein in GLUT4 vesicles from adipocytes. J Biol Chem 1998; 273(6): 3582-7.
96. Huang G, Buckler-Pena D, Nauta T, et al. Insulin responsiveness of glucose transporter 4 in 3T3-L1 cells depends on the presence of sortilin. Mol Biol Cell 2013; 24(19): 3115-22.
97. Ariga M, Nedachi T, Katagiri H, Kanzaki M. Functional role of sortilin in myogenesis and development of insulin-responsive glucose transport system in C2C12 myocytes. J Biol Chem 2008; 283(15): 10208-20.
98. Jedrychowski MP, Gartner CA, Gygi SP, et al. Proteomic analysis of GLUT4 storage vesicles reveals LRP1 to be an important vesicle component and target of insulin signaling. J Biol Chem 2010; 285(1): 104-14.
99. Vassilopoulos S, Esk C, Hoshino S, et al. A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism. Science 2009; 324(5931): 1192-6.
100. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010; 466(7307): 714-9.
101. Bogan JS. Regulation of glucose transporter translocation in health and diabetes. Annu Rev Biochem 2012; 81: 507-32.
102. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, highdensity lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40(2): 189-97.
103. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40(2): 161-9.
104. Wallace C, Newhouse SJ, Braund P, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: Serum urate and dyslipidemia. Am J Hum Genet 2008; 82(1): 139-49.
105. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009; 41(1): 56-65.
106. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009; 41(1): 47-55.
107. Sabatti C, Service SK, Hartikainen AL, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009; 41(1): 35-46.
108. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466(7307): 707-13.
109. Lange LA, Hu Y, Zhang H, et al. Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol. Am J Hum Genet 2014; 94(2): 233-45.
110. Global Lipids Genetics C, Willer CJ, Schmidt EM, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013; 45(11): 1274-83.
111. Tall AR, Ai D. Sorting out sortilin. Circ Res 2011; 108(2): 158-60.
112. Linsel-Nitschke P, Samani NJ, Schunkert H. Sorting out cholesterol and coronary artery disease. N Engl J Med 2010; 363(25): 2462-3.
113. Kjolby M, Andersen OM, Breiderhoff T, et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab 2010; 12(3): 213-23.
114. Gustafsen C, Kjolby M, Nyegaard M, et al. The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion. Cell Metab 2014; 19(2): 310-8.
115. Stockley RA, Dirksen A, Stolk J. Alpha-1 antitrypsin deficiency: the European experience. COPD 2013; 10 Suppl 1: 50-3.
116. De Serres FJ, Blanco I, Fernandez-Bustillo E. PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data. Mon Arch Chest Dis 2007; 67(4): 184-208.
117. Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest 2005; 128(3): 1179-86.
118. Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleveland Clin J Med 1994; 61(6): 461-7.
119. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992; 357(6379): 605-7.
120. Gelling CL, Dawes IW, Perlmutter DH, Fisher EA, Brodsky JL. The endosomal protein-sorting receptor sortilin has a role in trafficking alpha-1 antitrypsin. Genetics 2012; 192(3): 889-903.
121. Journet A, Chapel A, Kieffer S, et al. Towards a human repertoire of monocytic lysosomal proteins. Electrophoresis 2000; 21(16): 3411-9.
122. Journet A, Chapel A, Kieffer S, Roux F, Garin J. Proteomic analysis of human lysosomes: Application to monocytic and breast cancer cells. Proteomics 2002; 2(8): 1026-40.
123. Hille-Rehfeld A. Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes. Biochim Biophys Acta 1995; 1241(2): 177-94.
124. Nielsen MS, Jacobsen C, Olivecrona G, Gliemann J, Petersen CM. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem 1999; 274(13): 8832-6.
125. Ni X, Canuel M, Morales CR. The sorting and trafficking of lysosomal proteins. Histol Histopathol 2006; 21(8): 899-913.
126. Canuel M, Korkidakis A, Konnyu K, Morales CR. Sortilin mediates the lysosomal targeting of cathepsins D and H. Biochem Biophys Res Commun 2008; 373(2): 292-7.
127. Coutinho MF, Prata MJ, Alves S. A shortcut to the lysosome: The mannose-6-phosphate-independent pathway. Mol Genet Metab 2012; 107(3): 257-66.
128. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144(5): 646-74.
129. Weis SM, Cheresh DA. alphaV integrins in angiogenesis and cancer. Cold Spring Harbor Persp Med 2011; 1(1): a006478.
130. Vaegter CB, Jansen P, Fjorback AW, et al. Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. Nat Neurosci 2011; 14(1): 54-61.
131. Akil H, Perraud A, Melin C, Jauberteau MO, Mathonnet M. Finetuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival. PloS One 2011; 6(9): e25097.
132. Xiong J, Zhou L, Yang M, et al. ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro. Neurooncology 2013; 15(8): 990-1007.
133. Navarro V, Vincent JP, Mazella J. Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line. Biochem Biophys Res Commun 2002; 298(5): 760-4.
134. Martin S, Navarro V, Vincent JP, Mazella J. Neurotensin receptor- 1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterol 2002; 123(4): 1135-43.
135. Massa F, Devader C, Beraud-Dufour S, et al. Focal adhesion kinase dependent activation of the PI3 kinase pathway by the functional soluble form of neurotensin receptor-3 in HT29 cells. Int J Biochem Cell Biol 2013; 45(5): 952-9.
136. Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 2009; 8(8): 627-44.
137. Martin S, Vincent JP, Mazella J. Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J Neurosci 2003; 23(4): 1198-205.
138. Rogers ML, Bailey S, Matusica D, et al. ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex. J Neuroimmunol 2010; 226(1-2): 93-103.
139. Fauchais AL, Boumediene A, Lalloue F, et al. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome. Scand J Rheumatol 2009; 38(1): 50-7.
140. Fauchais AL, Lalloue F, Lise MC, et al. Role of endogenous brainderived neurotrophic factor and sortilin in B cell survival. J Immunol 2008; 181(5): 3027-38.
141. Gutierrez MG, Mishra BB, Jordao L, et al. NF-kappa B activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages. J Immunol 2008; 181(4): 2651-63.
142. Wahe A, Kasmapour B, Schmaderer C, et al. Golgi-to-phagosome transport of acid sphingomyelinase and prosaposin is mediated by sortilin. J Cell Sci 2010; 123(Pt 14): 2502-11.
143. Herda S, Raczkowski F, Mittrucker HW, et al. The sorting receptor Sortilin exhibits a dual function in exocytic trafficking of interferon-gamma and granzyme A in T cells. Immunity 2012; 37(5): 854-66.
144. Da Silva L, Neves BM, Moura L, Cruz MT, Carvalho E. Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochim Biophys Acta 2011; 1813(10): 1863-71.
145. Dicou E, Vincent JP, Mazella J. Neurotensin receptor-3/sortilin mediates neurotensin-induced cytokine/chemokine expression in a murine microglial cell line. J Neurosci Res 2004; 78(1): 92-9.
146. Larsen JV, Hansen M, Moller B, et al. Sortilin facilitates signaling of ciliary neurotrophic factor and related helical type 1 cytokines targeting the gp130/leukemia inhibitory factor receptor beta heterodimer. Mol Cell Biol 2010; 30(17): 4175-87.
147. Schecterson LC, Bothwell M. Neurotrophin receptors: Old friends with new partners. Develop Neurobiol 2010; 70(5): 332-8.
148. Skeldal S, Matusica D, Nykjaer A, Coulson EJ. Proteolytic processing of the p75 neurotrophin receptor: A prerequisite for signalling?: Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR). BioEssays 2011; 33(8): 614-25.
149. Reichardt LF. Neurotrophin-regulated signalling pathways. Phil Trans R Soc Lond Ser B Biol Sci 2006; 361(1473): 1545-64.
150. Schroder TJ, Christensen S, Lindberg S, et al. The identification of AF38469: An orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin. Bioorg Med Chem Lett 2014; 24(1): 177-80.
151. Saada S, Marget P, Fauchais AL, et al. Differential expression of neurotensin and specific receptors, NTSR1 and NTSR2, in normal and malignant human B lymphocytes. J Immunol 2012; 189(11): 5293-303.
152. Gutekunst CA, Torre ER, Sheng Z, et al. Stigmoid bodies contain type I receptor proteins SorLA/LR11 and sortilin: New perspectives on their function. J Histochem Cytochem 2003; 51(6): 841-52.
153. Xiang J, Yang H, Zhao T, et al. Huntingtin-associated protein 1 regulates postnatal neurogenesis and neurotrophin receptor sorting. J Clin Investig 2014; 124(1): 85-98.